A detailed history of Great West Life Assurance CO transactions in Iovance Biotherapeutics, Inc. stock. As of the latest transaction made, Great West Life Assurance CO holds 60,749 shares of IOVA stock, worth $494,496. This represents 0.0% of its overall portfolio holdings.

Number of Shares
60,749
Previous 60,012 1.23%
Holding current value
$494,496
Previous $481,000 18.71%
% of portfolio
0.0%
Previous 0.0%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$7.28 - $11.9 $5,365 - $8,770
737 Added 1.23%
60,749 $571,000
Q2 2024

Aug 12, 2024

BUY
$7.78 - $14.19 $125,522 - $228,941
16,134 Added 36.77%
60,012 $481,000
Q1 2024

May 13, 2024

BUY
$7.59 - $17.47 $157,705 - $362,991
20,778 Added 89.95%
43,878 $650,000
Q4 2023

Feb 13, 2024

SELL
$3.3 - $8.89 $3,712 - $10,001
-1,125 Reduced 4.64%
23,100 $187,000
Q3 2023

Nov 14, 2023

BUY
$4.44 - $8.79 $36,869 - $72,992
8,304 Added 52.16%
24,225 $110,000
Q2 2023

Aug 10, 2023

BUY
$5.36 - $9.06 $40,628 - $68,674
7,580 Added 90.88%
15,921 $113,000
Q1 2023

May 12, 2023

BUY
$5.53 - $8.22 $3,710 - $5,515
671 Added 8.75%
8,341 $51,000
Q4 2022

Feb 10, 2023

BUY
$5.62 - $10.0 $1,882 - $3,350
335 Added 4.57%
7,670 $49,000
Q3 2022

Nov 01, 2022

BUY
$9.53 - $13.11 $1,591 - $2,189
167 Added 2.33%
7,335 $70,000
Q2 2022

Aug 12, 2022

BUY
$6.38 - $18.33 $45,731 - $131,389
7,168 New
7,168 $79,000
Q2 2022

Aug 09, 2022

SELL
$6.38 - $18.33 $44,736 - $128,529
-7,012 Closed
0 $0
Q1 2022

May 12, 2022

BUY
$12.38 - $19.1 $1,993 - $3,075
161 Added 2.35%
7,012 $123,000
Q4 2021

Feb 14, 2022

BUY
$16.55 - $27.63 $2,532 - $4,227
153 Added 2.28%
6,851 $130,000
Q1 2021

May 17, 2021

SELL
$28.67 - $52.59 $13,188 - $24,191
-460 Reduced 6.43%
6,698 $211,000
Q3 2020

Nov 17, 2020

BUY
$27.75 - $36.3 $110,250 - $144,219
3,973 Added 124.74%
7,158 $235,000
Q3 2020

Nov 13, 2020

SELL
$27.75 - $36.3 $110,250 - $144,219
-3,973 Reduced 55.5%
3,185 $104,000
Q4 2019

Feb 11, 2020

BUY
$17.95 - $29.41 $128,486 - $210,516
7,158 New
7,158 $198,000
Q3 2019

Oct 25, 2019

SELL
$17.99 - $26.0 $261,538 - $377,988
-14,538 Closed
0 $0
Q4 2018

Feb 12, 2019

BUY
$7.51 - $11.93 $43,956 - $69,826
5,853 Added 67.39%
14,538 $124,000
Q1 2018

May 10, 2018

SELL
$8.1 - $19.5 $55,533 - $133,692
-6,856 Reduced 44.12%
8,685 $147,000
Q4 2017

Feb 09, 2018

BUY
$6.65 - $9.25 $103,347 - $143,754
15,541
15,541 $123,000

Others Institutions Holding IOVA

About IOVANCE BIOTHERAPEUTICS, INC.


  • Ticker IOVA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 157,800,992
  • Market Cap $1.28B
  • Description
  • Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...
More about IOVA
Track This Portfolio

Track Great West Life Assurance CO Portfolio

Follow Great West Life Assurance CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Great West Life Assurance CO , based on Form 13F filings with the SEC.

News

Stay updated on Great West Life Assurance CO with notifications on news.